Eight-year-old dog Rosie, once abandoned in bushland, found a new lease on life when Sydney tech entrepreneur Paul Conyngham adopted the staffy-shar pei mix from a local animal shelter in 2019, just as pandemic lockdowns were beginning.
Heartbreak followed in 2024, when Rosie was diagnosed with aggressive mast cell cancer. Conyngham invested heavily in veterinary chemotherapy and surgery, treatments that slowed but failed to shrink the tumours.
Over the Christmas break, a custom mRNA cancer vaccine produced stunning results: the tennis ball-sized tumour on Rosie’s hock has halved, leaving researchers leading the field of human cancer therapy amazed at the treatment’s potential.
To read more, click here.